Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab

Saved in:
Bibliographic Details
Published in:Biologics: Targets & Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030190427963392
collection WordPress RSS
FRELIP Feed Integration
container_title Biologics: Targets & Therapy
description
discipline_display Natural Sciences
discipline_facet Natural Sciences
format Online Article
RSS Article
genre Journal Article
id rss_article:18859
institution FRELIP
journal_source_facet Biologics: Targets & Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
Biology
Natural Sciences — Life Sciences
Natural Sciences
sub_discipline_display Natural Sciences — Life Sciences
sub_discipline_facet Natural Sciences — Life Sciences
subject_display Biology
Natural Sciences — Life Sciences
Natural Sciences
Biology
Natural Sciences — Life Sciences
Natural Sciences
subject_facet Biology
Natural Sciences — Life Sciences
Natural Sciences
title Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
title_auth Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
title_full Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
title_fullStr Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
title_full_unstemmed Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
title_short Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
title_sort successful and risk-minimizing treatment of ulcerative colitis by positive switch from jak inhibitors to ustekinumab
topic Biology
Natural Sciences — Life Sciences
Natural Sciences
url https://www.dovepress.com/successful-and-risk-minimizing-treatment-of-ulcerative-colitis-by-posi-peer-reviewed-fulltext-article-BTT